Key result
SCORE2 and SCORE2-OP outperform classical SCORE in predicting fatal and non-fatal cardiovascular events.
Why the study?
Despite the availability of contemporary SCORE2 and SCORE2-OP cardiovascular risk prediction models, the Republic of Kazakhstan continues to use the original SCORE scale in national screening, and primary care faces barriers to implementing modern risk assessment tools.
Does the implementation of SCORE2 and SCORE2-OP improve the prediction of fatal and non-fatal cardiovascular events compared to the classical SCORE scale in primary care populations in Kazakhstan?
Does the implementation of SCORE2 and SCORE2-OP improve the prediction of fatal and non-fatal cardiovascular events compared to the classical SCORE scale in primary care populations in Kazakhstan?
Answers are grounded in this paper and cite their sources.
Transitioning from the classical SCORE scale to SCORE2 and SCORE2-OP in Kazakhstan's primary healthcare screening programs can improve the prediction of both fatal and non-fatal cardiovascular events.
Cardiovascular diseases continue to be the leading cause of mortality worldwide, including in the Republic of Kazakhstan, accounting for a substantial proportion of premature disability and reduced life expectancy. Under current conditions, primary prevention strategies based on the timely identification of risk factors and comprehensive cardiovascular risk stratification continue to play a pivotal role, emphasizing the limited effectiveness of existing preventive approaches. This review examines the evolution of cardiovascular risk assessment tools, from the classical SCORE scale to the contemporary SCORE2 and SCORE2-OP models. Their methodological characteristics, clinical advantages, limitations, and potential applications in routine practice are analyzed. Despite the availability of more advanced risk prediction systems, Kazakhstan continues to utilize the original SCORE scale within the framework of the national screening program, while many healthcare information systems still lack automated cardiovascular risk calculation functions. Particular attention is paid to the organization of circulatory system disease screening in the Republic of Kazakhstan and to the barriers hindering the implementation of modern cardiovascular risk assessment tools at the primary healthcare level. Current evidence demonstrates the superior prognostic performance of the SCORE2 and SCORE2-OP scales compared with the classical SCORE model, particularly in predicting both fatal and non-fatal cardiovascular events. The article further discusses the prospects for integrating contemporary cardiovascular risk stratification algorithms into national CVD prevention programs. Special emphasis is placed on the implementation of SCORE2 and SCORE2-OP in the clinical practice of Kazakhstan as effective tools for cardiovascular risk assessment capable of enhancing preventive strategies, improving early detection of high-risk individuals, and reducing the burden of cardiovascular pathology.
No takes yet. Share an insight, caveat, or question.
Kerimkulova et al. (2026) conducted a review in Cardiovascular disease risk assessment in primary and outpatient care. SCORE2 and SCORE2-OP cardiovascular risk assessment models vs. Classical SCORE scale was evaluated on Prediction of fatal and non-fatal cardiovascular events. SCORE2 and SCORE2-OP scales demonstrate superior prognostic performance over the classical SCORE model in predicting fatal and non-fatal cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: